Ken Griffin Accelerate Diagnostics, Inc Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.51 - $17.1 $21,352 - $715,925	-41,867 Reduced 82.11%	9,120 $6,000
Q3 2022 Nov 14, 2022	SELL	$1.01 - $17.0 $1.15 Million - $19.3 Million	-1,136,274 Reduced 95.71%	50,987 $78,000
Q2 2022 Aug 15, 2022	BUY	$0.54 - $1.41 $631,424 - $1.65 Million	1,169,305 Added 6512.06%	1,187,261 $1.18 Million
Q1 2022 May 16, 2022	SELL	$1.4 - $5.15 $90,802 - $334,023	-64,859 Reduced 78.32%	17,956 $26,000
Q4 2021 Feb 14, 2022	SELL	$4.27 - $6.97 $129,820 - $211,908	-30,403 Reduced 26.85%	82,815 $432,000
Q3 2021 Nov 15, 2021	BUY	$5.31 - $8.25 $508,023 - $789,302	95,673 Added 545.3%	113,218 $660,000
Q2 2021 Aug 16, 2021	SELL	$6.81 - $9.23 $124,350 - $168,539	-18,260 Reduced 51.0%	17,545 $141,000
Q1 2021 May 17, 2021	BUY	$7.99 - $15.0 $174,709 - $327,990	21,866 Added 156.87%	35,805 $298,000
Q4 2020 Feb 16, 2021	SELL	$7.04 - $11.7 $22,865 - $38,001	-3,248 Reduced 18.9%	13,939 $106,000
Q3 2020 Nov 16, 2020	SELL	$9.98 - $18.04 $1.67 Million - $3.02 Million	-167,550 Reduced 90.7%	17,187 $183,000
Q1 2020 May 15, 2020	BUY	$4.62 - $18.74 $201,561 - $817,588	43,628 Added 30.92%	184,737 $1.54 Million
Q4 2019 Feb 14, 2020	BUY	$14.6 - $18.13 $1.13 Million - $1.41 Million	77,658 Added 122.39%	141,109 $2.39 Million
Q3 2019 Nov 14, 2019	SELL	$16.62 - $23.92 $651,088 - $937,066	-39,175 Reduced 38.17%	63,451 $1.18 Million
Q2 2019 Aug 14, 2019	BUY	$17.79 - $22.88 $1.57 Million - $2.02 Million	88,139 Added 608.4%	102,626 $2.35 Million
Q1 2019 May 15, 2019	SELL	$11.76 - $22.15 $631,900 - $1.19 Million	-53,733 Reduced 78.76%	14,487 $0
Q4 2018 Feb 14, 2019	BUY	$10.42 - $21.94 $148,516 - $312,710	14,253 Added 26.41%	68,220 $784,000
Q3 2018 Nov 13, 2018	BUY	$20.4 - $24.6 $596,618 - $719,451	29,246 Added 118.3%	53,967 $0
Q2 2018 Aug 10, 2018	SELL	$19.02 - $24.95 $91,961 - $120,633	-4,835 Reduced 16.36%	24,721 $0
Q3 2017 Nov 09, 2017	BUY	$21.1 - $25.15 $623,631 - $743,333	29,556	29,556 $664,000

Others Institutions Holding AXDX

# of Institutions

Shares Held

549K

Call Options Held

Put Options Held

View Full List

About Accelerate Diagnostics, Inc

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $169M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

More about AXDX

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account